BRR OpCo’s Novartis NVS Stock Holding History

BRR OpCo’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,525	Closed	-$216K	–	236
2021 Q1	$216K	Buy	+2,525	New	+$227K	0.03%	207
2019 Q2	–	Sell	-12,572	Closed	-$1.08M	–	204
2019 Q1	$1.08M	Buy	+12,572	New	+$1.01M	0.19%	48
2015 Q1	–	Sell	-2,503	Closed	-$208K	–	104
2014 Q4	$208K	Sell	2,503 -329	-12%	-$27.3K	0.08%	94
2014 Q3	$239K	Buy	2,832 +223	+9%	+$18K	0.1%	92
2014 Q2	$212K	Buy	+2,609	New	+$205K	0.09%	96

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BRR OpCo's NVS Position: Q2 2021 in Review

BRR OpCo sold out of Novartis (NVS) in Q2 2021, closing a stake of 2,525 shares — an estimated $216K sold.

BRR OpCo first reported a position in NVS in Q2 2014 and held it in 5 quarters. The position peaked at $1.08M in Q1 2019. 1,119 funds tracked by Wall St. Rank hold NVS as of Q2 2021.

BRR OpCo reported no remaining Novartis position as of Q2 2021 after selling out during the quarter.
BRR OpCo sold 2,525 Novartis shares in Q2 2021, an estimated $216K.
BRR OpCo first reported a position in Novartis in Q2 2014 and held it in 5 quarters.
BRR OpCo's Novartis position peaked at $1.08M in Q1 2019.
1,119 funds tracked by Wall St. Rank held Novartis as of Q2 2021.

Based on BRR OpCo's 13F filing for Q2 2021, filed 9 Aug 2021.